Other groups have found that in NLRP3-/- mice, the number of tumor-associated MDSCs was significantly decreased, and the mice displayed a better response to dendritic cell vaccination against melanoma than wild-type mice [60]. The gene discussed is NLRP3; the disease is melanoma.